SCHEMBL22037504

SCHEMBL22037504

CC1(C)c2cccc(-c3cccc(-c4ccc(-c5nc(-c6ccccc6)nc(-c6ccc(-c7cccnc7)cc6)n5)cc4)c3)c2-c2ccc3ccccc3c21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 4/20 0.41
CYP19A1 P11511 3/20 0.41
CYP11B2 P19099 3/20 0.41
CYP17A1 P05093 2/20 0.41
PDK2 Q15119 4/20 0.40
ALDH1A1 P00352 3/20 0.39
MAPT P10636 2/20 0.39
KDM4E B2RXH2 1/20 0.39
HPGD P15428 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2D6 P10635 2/20 0.37
CYP2C9 P11712 2/20 0.37
CLK4 Q9HAZ1 2/20 0.37
TSHR P16473 2/20 0.37
MEN1 O00255 1/20 0.37
GLA P06280 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22037530 0.99 CYP11B1 (0.40) CYP11B1CYP19A1CYP11B2CYP17A1PDK2
SCHEMBL22037487 0.99 CYP11B1 (0.40) CYP11B1CYP19A1CYP11B2CYP17A1PDK2
SCHEMBL22038931 0.98 PDK2 (0.39) CYP11B1CYP19A1CYP11B2CYP17A1PDK2
SCHEMBL22038046 0.96 ALDH1A1 (0.41) CYP11B1CYP19A1CYP11B2CYP17A1PDK2
SCHEMBL22037475 0.95 PDK2 (0.40) CYP11B1CYP19A1CYP11B2CYP17A1PDK2
SCHEMBL22037916 0.95 CYP11B1 (0.40) CYP11B1CYP19A1CYP11B2CYP17A1PDK2
SCHEMBL22039026 0.95 ALDH1A1 (0.40) CYP11B1CYP19A1CYP11B2CYP17A1PDK2
SCHEMBL22037943 0.95 ALDH1A1 (0.42) CYP11B1CYP19A1CYP11B2CYP17A1PDK2
SCHEMBL22038970 0.95 PDK2 (0.41) CYP11B1CYP19A1CYP11B2CYP17A1PDK2
SCHEMBL22038936 0.95 PDK2 (0.41) CYP11B1CYP19A1CYP11B2CYP17A1PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200168805-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME DOOSAN CORPORATION (KR) 2020-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200168805-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME ELOVL1, ELOVL6, ELOVL5 CYP11B1 1693/4885CYP19A1 1838/4885CYP11B2 1415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.